DNA tests for colon cancer aren't cost effective, study says

09/22/2010 | Reuters

Researchers said unless Medicare approves coverage of DNA testing for colon cancer or prices for the procedure drop considerably it will not be a cost-effective screening tool. Medicare already covers colonoscopy, flexible sigmoidoscopy, barium enema and fecal occult blood testing, all less expensive but effective colon cancer tests.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA